Posaconazole injection is indicated for prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections.
Generic Spiriva HandiHaler is indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease.
RK Pharma said the acquisition will give the company an exciting product portfolio, meaningful partnerships and a proven team with an impressive track record.
AbbVie accused Coherus of breaching a previous agreement, granting a license for a biosimilar of Humira, leading Coherus to file a restraining order to prevent termination of the licensing deal.